Skip to main content
. 2016 Jun 10;28(1):85–93. doi: 10.1681/ASN.2015111282

Figure 4.

Figure 4.

The presence of MAP17 does not change the expression level of SGLT2. (A) OK cells expressing pcDNA3.1-F7-hSGLT2 have been fixed with and exposed to an anti-F7 antibody and a fluorescent anti-antibody. (B) OK cells expressing a combination of pcDNA3.1-F7-hSGLT2 and pcDNA3.1-hMAP17-HA. Localization of SGLT2 and similar quantities are visible in both cases. The white scale bars indicate distances of 10 µm and the yellow bar indicates the z axis.